CRIS Current Research Information System

TREVISANI, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.255
EU - Europa 8.222
AS - Asia 2.617
AF - Africa 527
SA - Sud America 21
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.233
GB - Regno Unito 2.419
IT - Italia 1.318
SE - Svezia 1.062
DE - Germania 1.034
CN - Cina 1.001
VN - Vietnam 807
UA - Ucraina 538
IN - India 533
IE - Irlanda 410
FR - Francia 345
RU - Federazione Russa 327
CH - Svizzera 261
TG - Togo 227
EE - Estonia 192
ZA - Sudafrica 190
JO - Giordania 93
BG - Bulgaria 92
FI - Finlandia 55
SG - Singapore 49
CI - Costa d'Avorio 44
SC - Seychelles 39
JP - Giappone 37
IR - Iran 32
GR - Grecia 27
NL - Olanda 27
BE - Belgio 23
NG - Nigeria 22
HR - Croazia 17
ES - Italia 16
AT - Austria 14
AU - Australia 14
CA - Canada 13
LB - Libano 11
RO - Romania 10
UZ - Uzbekistan 9
CZ - Repubblica Ceca 7
EC - Ecuador 7
HK - Hong Kong 7
PH - Filippine 7
DK - Danimarca 6
BR - Brasile 5
CL - Cile 5
EU - Europa 5
KR - Corea 5
MX - Messico 5
TR - Turchia 5
EG - Egitto 4
LU - Lussemburgo 4
MK - Macedonia 4
PL - Polonia 4
PT - Portogallo 4
TW - Taiwan 4
ID - Indonesia 3
NZ - Nuova Zelanda 3
PE - Perù 3
SV - El Salvador 3
BD - Bangladesh 2
BH - Bahrain 2
KZ - Kazakistan 2
MY - Malesia 2
PK - Pakistan 2
TH - Thailandia 2
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
DZ - Algeria 1
GE - Georgia 1
HU - Ungheria 1
IM - Isola di Man 1
LT - Lituania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 22.664
Salva come PNG Salva come JPEG
Città #
Southend 2.172
Fairfield 1.741
Chandler 1.125
Ashburn 861
Woodbridge 757
Seattle 652
Wilmington 650
Houston 648
Princeton 560
Cambridge 543
Dong Ket 540
Dublin 409
Ann Arbor 366
Jacksonville 359
Bologna 285
Bern 239
Westminster 228
Lomé 227
Nanjing 204
Padova 197
Berlin 158
Saint Petersburg 105
Boardman 97
Shenyang 96
Amman 93
San Diego 93
Sofia 90
Jinan 82
Medford 79
Hebei 75
Milan 73
Beijing 72
New York 72
Turin 71
Changsha 70
Nanchang 70
Florence 69
Mülheim 68
Redmond 67
Dearborn 65
Los Angeles 59
Redwood City 47
Helsinki 45
Abidjan 44
Bremen 44
Tianjin 44
Des Moines 43
Falls Church 38
Mahé 38
Norwalk 38
Olalla 38
Rome 35
Jiaxing 32
Mountain View 32
Tokyo 32
Hangzhou 31
Zhengzhou 28
Bühl 27
Singapore 25
Verona 25
London 24
Brussels 23
Abeokuta 22
Kunming 22
Ningbo 20
Pune 20
Paris 19
Washington 18
Haikou 16
Lanzhou 16
Zanjan 16
Taiyuan 15
Taizhou 13
Chicago 12
Fuzhou 12
Kuban 12
Guangzhou 11
Lappeenranta 10
San Venanzo 10
Melbourne 9
Reggio Nell'emilia 9
Genoa 8
Napoli 8
Ardabil 7
Buffalo 7
Frankfurt Am Main 7
Hefei 7
Lübeck 7
Monmouth Junction 7
Moscow 7
Saint Louis 7
San Francisco 7
Boydton 6
Costa Mesa 6
Fremont 6
Guayaquil 6
Leawood 6
Phoenix 6
San Jose 6
Wuhan 6
Totale 15.629
Salva come PNG Salva come JPEG
Nome #
Alcol, sindrome feto-alcolica, apparato ematopoietico, muscolo-scheletrico, respiratorio, cute e reni. 177
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 173
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 172
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 169
null 164
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 155
Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation. 154
g-hydroxybutyrate as a treatment for alcoholism. 153
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 152
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 150
Art in hospital: its impact on the feelings and emotional state of patients admitted to an Internal Medicine Unit. 148
Ablation and resection for hepatocellular carcinoma within Milan criteria and high alpha-foetoprotein levels 145
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 145
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma 141
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20 year multicentre experience. 141
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 138
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 137
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 136
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 136
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 136
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 133
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 133
Cardiac electrophysiological abnormalities in patients with cirrhosis. 131
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 131
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 131
Adequate Interval For Hepatocellular Carcinoma Surveillance 127
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 126
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 126
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 125
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 124
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 123
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 123
Insufficienza epatica acuta ed epatite subacuta. 123
Alfa-fetoprotein in hepatocellular carcinoma (HCC): diagnostic and prognostic role, clinical and biological predictors. Analysis of 1099 patients. 122
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 121
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 121
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept 121
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study 120
Telangiectasia as a presenting sign of Graves’ disease. 120
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. 119
Monofocal hepatocellular carcinoma: How much does size matter? 119
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 117
null 117
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 116
Metabolic disorders across hepatocellular carcinoma in Italy 116
The changing scenario of hepatocellular carcinoma in Italy: an update 116
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing Lamivudine resistance. 115
Gamma-hydroxybutyric acid plus naltrexone in the treatment of alcoholics resistant to monotherapy. 114
Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma 114
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 114
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 113
Hepatic decompensation is the major driver of death In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. 112
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. 111
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 110
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 109
Alcolismo 108
C-type natriuretic peptide (CNP) favours natriuresis in pre-ascitic cirrhotic patients. 108
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 108
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation. 108
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 108
Trattamento farmacologico della intossicazione acuta, sindrome post-sbornia e sindrome d’astinenza da alcol. 107
Alcohol misuse and traffic accidents 107
Torsade de pointes” during amiodarone infusion in cirrhotic woman with the prolonged QT interval. 107
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. 107
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 106
AASLD single-topic research conference on hepatocellular carcinoma: Conference proceedings 106
Osteonecrosis of the jaw during sorafenib therapy for hepatocellular carcinoma 106
Retrospective analysis of dose–response for HCC lesions treated with 90Y resin microspheres. 106
Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome 106
What is the probability of being too old for salvage transplantation after hepatocellular carcinoma resection? 105
Serum SCCA-IgM as a predictor of hepatocellular carcinoma in patients with liver cirrhosis 105
Prognostication of the outcome of hepatocellular carcinoma: how to rely on science instead of the art of Nostradamus 104
Portal vein arterialization increases liver regeneration in acute liver failure induced by extended hepatectomy or toxin administration in the rat 103
Impact of evidence-based medicine on treatment of patients with unresectable hepatocellular carcinoma 103
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case controlled study 103
Differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma: Potential role of double tracer PET with 11C-Acetate and 18F-FDG 103
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype 102
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use 102
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 102
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis. 102
Trattamento dell’epatopatia alcolica 101
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. 101
Hyperkeratosis of nipple skin during sorafenib treatment 101
Alpha-fetoprotein in hepatocellular carcinoma surveillance: Wake not the dead 101
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 101
QT Interval Correction in Patients with Cirrhosis 101
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. 101
Suppression of craving for gamma-hydroxybutyric acid by naltrexone administration: three case reports. 100
Years of life that could be saved from prevention of hepatocellular carcinoma. 100
Effects of the combined treatment with thalidomide and megestrol in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study. 100
Basi scientifiche per la definizione delle linee guida in ambito clinico per l’epatocarcinoma. 99
Suppression of craving for gamma-hydroxybutyric acid by naltrexone administration: three case reports. 97
Metronomic capecitabine in advanced hepatocellular carcinoma patients:a phase II study. 97
Hepatocellular carcinoma in non-cirrhotic liver: A reappraisal. 97
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 97
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 97
Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis 96
A Liver Index and its Relationship to Indices of HCC Aggressiveness 95
Patients with Barcelona Clinic Liver Cancer Stages B and C Hepatocellular Carcinoma: Time for a Subclassification 95
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection. 94
Totale 11.838
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.417
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.151 932 156 77 327 635 654 790 789 819 436 199 337
2020/20213.433 702 243 114 131 70 155 99 182 295 208 165 1.069
2021/20224.675 309 168 267 346 434 247 105 325 197 253 1.290 734
2022/20235.123 516 763 267 604 332 366 178 261 908 125 418 385
2023/20241.577 104 241 114 133 148 286 115 102 111 102 60 61
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 23.238